| 生物活性 | |||
|---|---|---|---|
| 靶点 | 
 | ||
| 描述 | Bentamapimod (AS 602801) induces cell death in a dose-dependent manner across various cancer cell lines including human pancreatic, non-small cell lung, ovarian cancer, and glioblastoma cells, without affecting the viability of normal human fibroblasts. It also hinders the self-renewal and tumor-initiating capabilities of cancer stem cells that survive treatment with Bentamapimod (AS 602801)[2]. | ||
| 作用机制 | AS-602801 is an ATP competitive JNK inhibitor.[1] | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 2.19mL 0.44mL 0.22mL | 10.93mL 2.19mL 1.09mL | 21.86mL 4.37mL 2.19mL | 
| 参考文献 | 
|---|
| [1]Zhao J, Pei G. Evoking plasmin for beta-amyloid clearance. Cell Res. 2008 Aug;18(8):803-4. |